TR201109159A2 - Film-coated tablet composition containing eplerenone. - Google Patents

Film-coated tablet composition containing eplerenone.

Info

Publication number
TR201109159A2
TR201109159A2 TR2011/09159A TR201109159A TR201109159A2 TR 201109159 A2 TR201109159 A2 TR 201109159A2 TR 2011/09159 A TR2011/09159 A TR 2011/09159A TR 201109159 A TR201109159 A TR 201109159A TR 201109159 A2 TR201109159 A2 TR 201109159A2
Authority
TR
Turkey
Prior art keywords
film
composition containing
coated tablet
tablet composition
containing eplerenone
Prior art date
Application number
TR2011/09159A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/09159A priority Critical patent/TR201109159A2/en
Publication of TR201109159A2 publication Critical patent/TR201109159A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Mevcut buluş, eplerenon içeren yeni, çözünebilir ve kolay üretilebilir farmasötik formülasyonlar ile ilişkilidir.The present invention relates to new, soluble and easily manufactured pharmaceutical formulations containing eplerenone.

TR2011/09159A 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone. TR201109159A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/09159A TR201109159A2 (en) 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone
TR2011/09159A TR201109159A2 (en) 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone.

Publications (1)

Publication Number Publication Date
TR201109159A2 true TR201109159A2 (en) 2012-04-24

Family

ID=45524932

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone
TR2011/09160A TR201109160A2 (en) 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone.
TR2011/09159A TR201109159A2 (en) 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone.
TR2011/09158A TR201109158A2 (en) 2010-09-20 2011-09-19 Easily soluble pharmaceutical composition containing eplerenone.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone
TR2011/09160A TR201109160A2 (en) 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/09158A TR201109158A2 (en) 2010-09-20 2011-09-19 Easily soluble pharmaceutical composition containing eplerenone.

Country Status (2)

Country Link
TR (4) TR201007653A2 (en)
WO (1) WO2012050539A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109925293B (en) * 2019-03-15 2022-02-01 南京卡文迪许生物工程技术有限公司 Eplerenone oral solid preparation and preparation method thereof
CN113995719B (en) * 2021-10-19 2023-06-23 河南中盛生物工程有限公司 Application of sodium carboxymethyl cellulose in improving amoxicillin and colistin sulfate injection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77669C (en) 1983-04-13 1989-04-10 Ciba Geigy Ag 20-SPIROXANER OCH ANALOGER, SOM INNEHAOLLER EN OEPPEN RING E, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARATION.
UA74141C2 (en) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Oral pharmaceutical compositions comprising micronized eplerenone (variants), method for its production and method for treating aldosterone-mediated states (variants)
DE60019741T2 (en) 1999-12-08 2006-03-02 Pharmacia Corp., Chicago NANOPARTICLE COMPOSITIONS CONTAINING EPLERENONE
EP1280533A2 (en) * 2000-05-11 2003-02-05 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
WO2007012960A1 (en) * 2005-07-29 2007-02-01 Glenmark Pharmaceuticals Limited Pharmaceutical compositions of eplerenone
US20100086586A1 (en) * 2006-12-21 2010-04-08 Brett Antony Mooney Pharmaceutical Composition

Also Published As

Publication number Publication date
TR201007653A2 (en) 2012-04-24
TR201109160A2 (en) 2012-04-24
WO2012050539A1 (en) 2012-04-19
TR201109158A2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
GB201106750D0 (en) Novel compounds
WO2013103832A3 (en) Personal care compositions containing ionic silicone and film-forming agent
UA109464C2 (en) Spiro-oxindoles as mdm2 antagonists
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
BR112015002824A2 (en) compound, use of a compound, pharmaceutical composition, and combination pharmaceutical product.
PH12015501096A1 (en) Composition for immediate and extended release
EA201591830A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING EVEROLIMUS
TR201821285T4 (en) Pharmaceutical formulations containing a CCR3 antagonist.
MX2014001368A (en) Stable anti-inflammatory solutions for injection.
EA201590932A1 (en) COMPOSITIONS CONTAINING VORTIOKSETIN AND DONEPEZIL
CL2013000069A1 (en) Compounds derived from fused heterocycles, s1p modulators; pharmaceutical composition; and use in neurodegenerative diseases.
CY1126099T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE SORAFENIB TOSYLATE
TR201100150A2 (en) Water soluble dosage forms
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
HRP20130082A2 (en) Pharmaceutical composition with sustained release of trimetazidine
BR112014032501A2 (en) compound and pharmaceutical composition.
TR201109159A2 (en) Film-coated tablet composition containing eplerenone.
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
EP2569327A4 (en) Eif4e binding peptides
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
CL2012001759A1 (en) 8-hydroxyquinoline-7-carboxamide derived compounds; pharmaceutical composition.
TR201007926A1 (en) Prasugrel tablet formulations.